Histological variants of urothelial carcinoma predict no response to neoadjuvant chemotherapy (2022)
- Authors:
- USP affiliated authors: LEITE, KATIA RAMOS MOREIRA - FM ; SROUGI, MIGUEL - FM ; NAHAS, WILLIAM CARLOS - FM
- Unidade: FM
- DOI: 10.1016/j.clgc.2021.07.011
- Subjects: QUIMIOTERAPIA ADJUVANTE; NEOPLASIAS DA BEXIGA; NEOPLASIAS UROGENITAIS
- Language: Inglês
- Imprenta:
- Source:
- Título: Clinical genitourinary cancer
- ISSN: 1558-7673
- Volume/Número/Paginação/Ano: v. 20, n. 1, p. E1-E6, 2022
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
LEITE, Katia Ramos Moreira et al. Histological variants of urothelial carcinoma predict no response to neoadjuvant chemotherapy. Clinical genitourinary cancer, v. 20, n. 1, p. E1-E6, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.clgc.2021.07.011. Acesso em: 05 ago. 2025. -
APA
Leite, K. R. M., Borges, L. L., Ribeiro Filho, L., Chade, D., Coelho, R. F., Cordeiro, M., et al. (2022). Histological variants of urothelial carcinoma predict no response to neoadjuvant chemotherapy. Clinical genitourinary cancer, 20( 1), E1-E6. doi:10.1016/j.clgc.2021.07.011 -
NLM
Leite KRM, Borges LL, Ribeiro Filho L, Chade D, Coelho RF, Cordeiro M, Srougi M, Nahas WC. Histological variants of urothelial carcinoma predict no response to neoadjuvant chemotherapy [Internet]. Clinical genitourinary cancer. 2022 ; 20( 1): E1-E6.[citado 2025 ago. 05 ] Available from: https://doi.org/10.1016/j.clgc.2021.07.011 -
Vancouver
Leite KRM, Borges LL, Ribeiro Filho L, Chade D, Coelho RF, Cordeiro M, Srougi M, Nahas WC. Histological variants of urothelial carcinoma predict no response to neoadjuvant chemotherapy [Internet]. Clinical genitourinary cancer. 2022 ; 20( 1): E1-E6.[citado 2025 ago. 05 ] Available from: https://doi.org/10.1016/j.clgc.2021.07.011 - The Obstructed Bladder: Expression of Collagen, Matrix Metalloproteinases, Muscarinic Receptors, and Angiogenic and Neurotrophic Factors in Patients With Benign Prostatic Hyperplasia
- Downregulation of miR-29b is associated with Peyronie's disease
- GSTM1, GSTT1, GSTP1 Polymorphisms, Quality of Life, Habits, Environmental Exposure and Predisposition to Bladder Cancer
- miR-618: possible control over TIMP-1 and its expression in localized prostate cancer
- Expression of micro-RNAs and genes related to angiogenesis in ccRCC and associations with tumor characteristics
- Polymorphism in the PBX1 gene is related to cystinuria in Brazilian families
- Combined spinal and general anesthesia attenuate tumor promoting effects of surgery. An experimental animal study
- The phenomenon of epithelial-mesenchymal transition is associated with the progression of prostate cancer
- miR-29b enhances prostate cancer cell invasion independently of MMP-2 expression
- GLUT1 Expression Is Related to Tumor Recurrence and Survival in Renal Cell Carcinoma Clear Cell Type
Informações sobre o DOI: 10.1016/j.clgc.2021.07.011 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
